share_log

西藏药业(600211.SH):前三季度净利润7.92亿元,同比下降7.42%

Tibet Rhodiola Pharmaceutical Holding (600211.SH): The net income for the first three quarters was 0.792 billion yuan, a year-on-year decrease of 7.42%.

Gelonghui Finance ·  Oct 29, 2024 15:50

Gelonghui, October 29 | Tibet Pharmaceutical (600211.SH) released its report for the third quarter of 2024. The company's revenue for the first three quarters was 2.175 billion yuan, down 8.13% year on year; net profit attributable to shareholders of listed companies was 0.792 billion yuan, down 7.42% year on year; basic earnings per share were 2.46 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment